Zinc Citrate Find Assay

Description: 5-HT4 receptor agonist and 5-HT3 receptor antagonist. Displays no activity at D2, ?1, ?2, 5-HT1 and 5-HT2 receptors. Gastroprokinetic agent; increases gastric emptyin

Description: 5-HT4 receptor agonist and 5-HT3 receptor antagonist. Displays no activity at D2, ?1, ?2, 5-HT1 and 5-HT2 receptors. Gastroprokinetic agent; increases gastric emptyin

Description: 5-HT4 receptor agonist and 5-HT3 receptor antagonist. Displays no activity at D2, ?1, ?2, 5-HT1 and 5-HT2 receptors. Gastroprokinetic agent; increases gastric emptyin

Description: Potent cell permeable JAK3 inhibitor (IC50 = 1nM). Shows also JAK-1 inhibitory activity. Immunosuppressive and anti-inflammatory agent. Inhibits signaling through heterodimeric receptors associated with JAK3, JAK1, or both of them, with functional selectivity over JAK2-paired receptors. Blocks downstream STAT signaling, resulting in potent inhibition of several cytokines, including interleukins 2, 4, 7, 9, 15 and 21, which are integral to lymphocyte activation, function and proliferation. Investigated for several autoimmune disorders including, rheumatoid arthritis and psoriasis. Potent and selective inhibitor of HIV-1 replication and virus reactivation in vitro. It is investigated against the spread of the SARS-CoV-2 (COVID-19). PRK1 inhibitor.

Description: Sildenafil Citrate is a potent inhibitor of cGMP-specific phosphodiesterase including PDE5 with IC50 values of 3.6 nM.[1] PDE5 (cGMP-specific phosphodiesterase type 5) is an enzyme from the phosphodiesterase class.

Description: Sildenafil Citrate is a potent inhibitor of cGMP-specific phosphodiesterase including PDE5 with IC50 values of 3.6 nM.[1] PDE5 (cGMP-specific phosphodiesterase type 5) is an enzyme from the phosphodiesterase class.

Description: Sildenafil Citrate is a potent inhibitor of cGMP-specific phosphodiesterase including PDE5 with IC50 values of 3.6 nM.[1] PDE5 (cGMP-specific phosphodiesterase type 5) is an enzyme from the phosphodiesterase class.

Description: Sildenafil Citrate is a potent inhibitor of cGMP-specific phosphodiesterase including PDE5 with IC50 values of 3.6 nM.[1] PDE5 (cGMP-specific phosphodiesterase type 5) is an enzyme from the phosphodiesterase class.

Description: Oxeladin Citrate

Description: Oxeladin Citrate

Description: Oxeladin Citrate

Description: Oxeladin Citrate

Description: Lithium Citrate is the active component of Lithium which is a drug used in treatment of psychiatric disease [1].Lithium Citrate has shown the effects on metabolic and signaling pathways in the brain based on the specific clinical condition and disease model [2].

Description: Lithium Citrate is the active component of Lithium which is a drug used in treatment of psychiatric disease [1].Lithium Citrate has shown the effects on metabolic and signaling pathways in the brain based on the specific clinical condition and disease model [2].